Why the study?
Although deletion of AT2R protects against high fat diet-induced metabolic dysfunctions, the role of AT2R in obesity-induced cardiac hypertrophy remains unclear.
Does deletion or inhibition of AT2R prevent high fat diet-induced cardiac hypertrophy and hypercholesterolemia in mice?
Does deletion or inhibition of AT2R prevent high fat diet-induced cardiac hypertrophy and hypercholesterolemia in mice?
AT2R mediates obesity-induced cardiac hypertrophy and hypercholesterolemia, suggesting it may be a potential therapeutic target for obesity-related cardiac remodeling.
Answers are grounded in this paper and cite their sources.
AT2R loss attenuates diet-induced cardiac remodeling in mice; hypothesis-generating for human translation, should not yet change practice.
Obesity is the major risk factor for several cardiovascular and metabolic disorders. Previous studies reported that deletion of Angiotensin II type 2 receptor (AT2R) protects against metabolic dysfunctions induced by high fat (HF) diet. However, the role of AT2R in obesity-induced cardiac hypertrophy remains unclear. Male AT2R knockout (AT2RKO) and wild type (AT2RWT) mice were fed with control or HF diet for 10 weeks. HF diet increased cardiac expression of AT2R in obese mice. Deletion of AT2R did not affect body weight gain, glucose intolerance and fat mass gain induced by HF feeding. However, loss of AT2R prevented HF diet-induced hypercholesterolemia and cardiac remodeling. Mechanistically, we found that pharmacological inhibition or knockdown of AT2R prevented leptin-induced cardiomyocyte hypertrophy in vitro. Collectively, our results suggest that AT2R is involved in obesity-induced cardiac hypertrophy.
No takes yet. Share an insight, caveat, or question.
Lima et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: